Positron emission tomography. Its cost-effectiveness;POSITRONENEMISSIONSTOMOGRAPHIE. KOSTEN-NUTZEN-GESICHTSPUNKTE

Radiologe

Volumn 36, Issue 4, 1996, Pages 337-344

  Kuwert, T ^a   Matheja, P ^a   Vollet, B ^a   Lottes, G ^a   Schafers M ^a   Schober, O ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

cardiology; cost effectiveness; neurology; oncology; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CARDIOLOGY; COST EFFECTIVENESS ANALYSIS; HUMAN; NEUROLOGY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY;

BLOOD GLUCOSE; BRAIN DISEASES; BRAIN NEOPLASMS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; ENERGY METABOLISM; HUMANS; NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029979112     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050080     Document Type: Article

References (34)

1. Shtern F (1992) Positron emission tomography as a diagnostic tool. A reassessment based on literature review. Invest Radiol 27: 165-168
2. Wagner HN Jr (1992) Positron emission tomography at the turn of the century: a perspective. Semin Nucl Med 22: 285-288
3. Hör G (1993) Positronen-Emissions-Tomographie (PET). Klinische Relevanz. Siemens - A901100-D694-1
4. Wahl RL, Hawkins RA, Larson SM, Hendee WR, Coleman RE, Holden RW, Frick MP Gatsonis C, Brown GS, Shtern F (1994) Proceedings of a National Cancer Institute workshop: PET in oncology - a clinical research agenda. Radiology 193: 604-606
5. Seitz RJ (1993) Positronen-Emissions-Tomographie in der Neurologie: Grundlagen - Fragestellungen - Indikationen. Akt Neurol 20: 177-183
6. Sawle GV (1995) Imaging the head: functional imaging. J Neurol Neurosurg Psychiatry 58: 132-144
7. Schelbert H, Czernin J (1994) Kardiologische Anwendungsbereiche der Positronen-Emissions-Tomographie. Wien Klin Wochenschr 15: 487-495
8. Gilman S (1992) Advances in neurology (first of two parts). N Engl J Med 326: 1608-1616
9. Schwaiger M (1994) Myocardial perfusion imaging with PET. J Nucl Med 35: 693-698
10. Schroter G, Schneider-Eicke J, Schwaiger M (1994) Assessment of tissue viability with fiuorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging. Herz 19: 42-50
11. Hawkins RA, Hoh C, Glaspy J, Rege S, Choi Y, Phelps ME (1994) Positron emission tomography scanning in cancer. Cancer Invest 12: 74-87
12. Arbeitsgemeinschaft PET der Deutschen Gesellschaft für Nuklear Medizin (1994) Positronen-Emissions-Tomographie. Klinische Forschung, diagnostische Wertigkeit, zukünftige Entwicklung: Standortbestimmung 1994. Nucl Med 33: 145-153
13. Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF (1996) Klinische Wertigkeit der Positronen-Emissions-Tomographie (PET) in der Onkologie: Ergebnisse der ersten Konsensuskonferenz in Frankfurt am 8.9, 1995. Nucl Med 35: 42-52
14. Heiss WD (1995) Positronen-Emissions-Tomographie (PET): Klinische Wertigkeit in Neurologie und Psychiatrie. Dtsch Ärztebl 92: B-372-B-377
15. Stöcklin G (1992) Tracers for metabolic imaging of brain and heart: radiochemistry and radiopharmacology. Eur J Nucl Med 19: 527-551
16. Gould KL, Goldstein RA, Mullani NA (1989) Economic analysis of clinical positron emission tomography of the heart with rubidium-82. Nucl Med 30: 707-717
17. Conti PS, Keppler JS, Halls JM (1994) Positron emission tomography: A financial and operational analysis. AJR 162: 1279-1286
18. Gleason JM, Frick MP (1990) The expected value of cash flows in the economic analysis of clinical positron emission tomography of the heart. J Nucl Med 31: 1893-1894 (letter)
19. Einheitlicher Bewertungsmaßstab 1996 (EBM). Deutscher Ärzteverlag 1996
20. Gebührenordnung für Ärzte 1996. Eigenpublikation der Privatärztlichcn Verrechnungsstellen 1996
21. LaPuma J, Lawlor EF (1990) Quality-adjusted life-years: ethical implications for physicians. JAMA 263: 2917-2919
22. Hillmann BJ (1994) Outcomes research and cost-effectiveness analysis for diagnostic imaging. Radiology 193: 307-310
23. Thornbury JR (1994) Eugene W, Caldwell Lecture: Clinical efficacy of diagnostic imaging: love it or leave it. AJR 162: 1-8
24. Mackenzie R, Dixon AK (1995) Measuring the effects of imaging: an evaluate framework. Clin Radiol 50: 513-518
25. Gur D, King JL, Rockette HE et al (1990) Practical issues of experimental ROC analysis: selection of controls. Invest Radiol 25: 583-586
26. Henkleman RM, Kay I, Bronskill J (1990) Receiver operator characteristics (ROC) analysis without truth. Med Decis Making 10: 24-29
27. ACC/AHA Task Force (1995) Guidelines for clinical use of cardiac radionuclide imaging. JACC 25: 521-547
28. Patterson RE, Eisner RL, Horowitz SF (1995) Comparison of cost-effectiveness and utility of exercise ECG. single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 91: 54-65
29. Hunink MGM (1995) Positron emission tomography compared to single photon emission computed tomography in the evaluation of myocardial viability: a preliminary cost-effectiveness analysis. In: Van der Wall et al. (eds) Cardiac positron emission tomography. Kluwer, Amsterdam, pp 97-102
30. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ (1995) PET-FDG imaging and transthoracic nedle lung aspiration biopsy in evaluation of pulmonary lesions: a comparative risk-benefit analysis. Chest 108: 441-446
31. Institute for Clinical PET (ICP) Solitary Pulmonary Nodule Task Force (1994) Clinical application and economic implications of PET in the assessment of solitary pulmonary nodules: a retrospective study. Abstract from the 1994 ICP meeting. ICP - CE-SPN-94.001
32. Kuwert T, Matheja P, Schober O (1996) Effektivität der Diagnostik von PET und SPECT bei degenerativen Hirnkrankheiten und Hirntumoren. Nuklearmediziner 19: 51-59
33. Engel J, Henry TR, Risinger MW, Mazziotta JC, Sutherling WW, Levesque MF, Phelps ME (1990) Presurgical evaluation for partial epilepsy: Relative contributions of chronic depth-electrode recording versus FDG-PET and scalpsphenoidal ictal EEG. Neurology 40: 1670-1677
34. Spencer SS (1994) The relative contributions of MRI. SPECT, and PET imaging in epilepsy. Epilepsia 35 [Suppl]: 72-89